Target Price | $14.51 |
Price | $22.26 |
Deviation |
34.80%
register free of charge
|
Number of Estimates | 28 |
28 Analysts have issued a price target XPeng ADR 2026 .
The average XPeng ADR target price is $14.51.
This is
34.80%
register free of charge
$26.04
16.98%
register free of charge
$7.00
68.53%
register free of charge
|
|
A rating was issued by 38 analysts: 27 Analysts recommend XPeng ADR to buy, 9 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the XPeng ADR stock has an average upside potential 2026 of
34.80%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Billion $ | 4.33 | 5.68 |
8.56% | 31.30% | |
EBITDA Margin | -30.40% | -12.39% |
9.52% | 59.25% | |
Net Margin | -29.86% | -8.06% |
2.67% | 73.01% |
35 Analysts have issued a sales forecast XPeng ADR 2024 . The average XPeng ADR sales estimate is
This results in the following potential growth metrics:
31 XPeng ADR Analysts have issued a net profit forecast 2024. The average XPeng ADR net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.68 | -0.60 |
5.66% | 64.29% | |
P/E | negative | |
EV/Sales | 2.66 |
31 Analysts have issued a XPeng ADR forecast for earnings per share. The average XPeng ADR <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the XPeng ADR stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
UBS | Locked ➜ Locked | Locked | Feb 24 2025 |
Macquarie | Locked ➜ Locked | Locked | Feb 07 2025 |
UBS | Locked ➜ Locked | Locked | Dec 05 2024 |
China Renaissance | Locked ➜ Locked | Locked | Nov 22 2024 |
Bernstein | Locked ➜ Locked | Locked | Nov 20 2024 |
Citigroup | Locked ➜ Locked | Locked | Nov 20 2024 |
JP Morgan | Locked ➜ Locked | Locked | Sep 05 2024 |
Analyst Rating | Date |
---|---|
Locked
UBS: Locked ➜ Locked
|
Feb 24 2025 |
Locked
Macquarie: Locked ➜ Locked
|
Feb 07 2025 |
Locked
UBS: Locked ➜ Locked
|
Dec 05 2024 |
Locked
China Renaissance: Locked ➜ Locked
|
Nov 22 2024 |
Locked
Bernstein: Locked ➜ Locked
|
Nov 20 2024 |
Locked
Citigroup: Locked ➜ Locked
|
Nov 20 2024 |
Locked
JP Morgan: Locked ➜ Locked
|
Sep 05 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.